Jointly led by Agence des Transitions and MedVallée Montpellier, with funding from the Novapec innovation fund and support from makesense, this fully subsidized program helps companies put together an effective, prioritized, and immediately actionable transition strategy.
Ten companies, ten individual journeys, one common goal: take concrete action for a more sustainable, resilient, and competitive economy.
Welcome to the first cohort:
Develops an innovative biotherapy treatment for cystic fibrosis, based on research conducted at University of Montpellier.
Biotech specializing in hearing disorders such as tinnitus and hearing loss, with unique expertise in preclinical evaluation.
Offers a digital solution to facilitate access to ongoing medical training for healthcare professionals.
Deploys charging stations for electric vehicles, with a sustainable and territorial approach.
Works on innovative therapeutic solutions in biotechnology, with an approach focused on personalized medicine.
Develops digital tools to improve healthcare coordination and the patient journey.
Biotech company specializing in targeted cancer treatments, notably for solid tumors.
Designs medical robots using cutting-edge technology for minimally invasive cancer treatment.
A major player in wind and solar energy, committed to the area's energy transition.
Offers innovative solutions for sustainable water management, particularly in urban areas.
This program provides a unique opportunity for companies to shape their ecological transition while strengthening their competitiveness.
